OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses
Christina Woopen, Urszula Konofalska, Katja Akgün, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9

Showing 9 citing articles:

Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID ‐19 in immunocompromised patients
Rhea Suribhatla, Thomas Starkey, Maria C. Ionescu, et al.
British Journal of Haematology (2023) Vol. 201, Iss. 5, pp. 813-823
Open Access | Times Cited: 33

Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience
Karolina Akinosoglou, Emmanouil-Angelos Rigopoulos, Georgia Kaiafa, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 118-118
Open Access | Times Cited: 29

Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis
Saad Alhumaid, Abbas Al Mutair, Jalal Alali, et al.
Diseases (2022) Vol. 10, Iss. 4, pp. 118-118
Open Access | Times Cited: 24

Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations
Juthaporn Cowan, Ashley Amson, Anna Christofides, et al.
International Journal of Infectious Diseases (2023) Vol. 134, pp. 228-238
Open Access | Times Cited: 15

The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination
David Baker, Eugenia Forte, Gareth Pryce, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 69, pp. 104425-104425
Open Access | Times Cited: 20

Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experience
Stefano Gelibter, Fiammetta Pirro, Lorenzo Saraceno, et al.
Journal of Neuroimmunology (2023) Vol. 383, pp. 578199-578199
Closed Access | Times Cited: 3

Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients
Rhea Suribhatla, Thomas Starkey, Maria C. Ionescu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5

Serum levels of neurofilament light chains in pediatric multiple sclerosis: a systematic review and meta-analysis
Alexandru-Ștefan Niculae, Lucia Elena Niculae, Cristiana Văcăraş, et al.
Journal of Neurology (2023) Vol. 270, Iss. 10, pp. 4753-4762
Closed Access | Times Cited: 1

Multiple drugs

Reactions Weekly (2023) Vol. 1946, Iss. 1, pp. 389-389
Closed Access

Page 1

Scroll to top